Tricitrates
NDC 17856-0677
Product Information
Tricitrates is a UNAPPROVED DRUG OTHER-approved product labeled by Atlantic Biologicals Corp.. This medication is used to make the urine less acidic. It is supplied as a orange product. This product entry covers the primary NDC 17856-0677 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 17856-0677?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- POTASSIUM CITRATE (UNII: EE90ONI6FF)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (Active Moiety)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SORBITOL (UNII: 506T60A25R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 309317 - citric acid 334 MG / potassium citrate 550 MG / sodium citrate 500 MG in 5 mL Oral Solution
- RxCUI: 309317 - citric acid 66.8 MG/ML / potassium citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
- RxCUI: 309317 - citric acid 334 MG / potassium citrate 550 MG / sodium citrate 500 MG per 5 ML Oral Solution
- RxCUI: 309317 - Citric Acid 66.8 MG/ML / K+ citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
- RxCUI: 309317 - Citric Acid 66.8 MG/ML / Pot citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution
* Please review the full disclaimer at the bottom of this page.